{"id":"https://openalex.org/W2463913093","doi":null,"title":"The plasma level of cathelicidin#LL37 in p atients with chronic hepatitis C virus","display_name":"The plasma level of cathelicidin#LL37 in p atients with chronic hepatitis C virus","publication_year":2010,"publication_date":"2010-01-01","ids":{"openalex":"https://openalex.org/W2463913093","mag":"2463913093"},"language":"en","primary_location":{"id":"mag:2463913093","doi":null,"is_oa":false,"landing_page_url":"http://www.wseas.us/e-library/conferences/2010/Malta/MEDICAL/MEDICAL-19.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null},"volume":null,"type":"article","is_traditional":true,"indexed_in":[],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5089965977","display_name":"Simona Alexandra Iacob","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Simona Iacob","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031905747","display_name":"Dorina Banica","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D B\u0103nic\u0103","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085531171","display_name":"Eugenia Panaitescu","orcid":"https://orcid.org/0000-0002-0083-8992","observed_orcids":["https://orcid.org/0000-0002-0083-8992"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Eugenia Panaitescu","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0002-0083-8992","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041643386","display_name":"Manole Cojocaru","orcid":"https://orcid.org/0000-0002-7192-7490","observed_orcids":["https://orcid.org/0000-0002-7192-7490"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Manole Cojocaru","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5103916816","display_name":"Diana Gabriela Iacob","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Diana Gabriela Iacob","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11103","display_name":"Antimicrobial Peptides and Activities","score":0.4733999967575073,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11103","display_name":"Antimicrobial Peptides and Activities","score":0.4733999967575073,"subfield":{"id":"https://openalex.org/subfields/2404","display_name":"Microbiology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10151","display_name":"Hepatitis C virus research","score":0.46309998631477356,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10966","display_name":"Liver physiology and pathology","score":0.0027000000700354576,"subfield":{"id":"https://openalex.org/subfields/2721","display_name":"Hepatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/chronic-hepatitis-c","display_name":"chronic hepatitis C","score":0.9229999780654907},{"id":"https://openalex.org/keywords/antimicrobial-peptides","display_name":"antimicrobial peptides","score":0.7639999985694885},{"id":"https://openalex.org/keywords/1-25-dihydroxyvitamin-d","display_name":"1,25-dihydroxyvitamin D","score":0.9639999866485596},{"id":"https://openalex.org/keywords/necroinflammation","display_name":"necroinflammation","score":0.8529999852180481},{"id":"https://openalex.org/keywords/liver-fibrosis","display_name":"liver fibrosis","score":0.9789999723434448},{"id":"https://openalex.org/keywords/anti-inflammatory-factors","display_name":"anti-inflammatory factors","score":0.593999981880188},{"id":"https://openalex.org/keywords/immune-inflammation","display_name":"immune inflammation","score":0.7020000219345093}],"concepts":[{"id":"https://openalex.org/C2777379352","wikidata":"https://www.wikidata.org/wiki/Q24739493","display_name":"Cathelicidin","level":4,"score":0.94338059425354},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7811795473098755},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.6557970643043518},{"id":"https://openalex.org/C3020491458","wikidata":"https://www.wikidata.org/wiki/Q131742","display_name":"Chronic hepatitis","level":3,"score":0.6228888630867004},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.553808331489563},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.534841001033783},{"id":"https://openalex.org/C2776408679","wikidata":"https://www.wikidata.org/wiki/Q708693","display_name":"Hepatitis C virus","level":3,"score":0.5211632251739502},{"id":"https://openalex.org/C3018023364","wikidata":"https://www.wikidata.org/wiki/Q425265","display_name":"Significant difference","level":2,"score":0.4930829703807831},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.4885600507259369},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4789588749408722},{"id":"https://openalex.org/C2780559512","wikidata":"https://www.wikidata.org/wiki/Q605709","display_name":"Fibrosis","level":2,"score":0.4493638575077057},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.3710595965385437},{"id":"https://openalex.org/C136449434","wikidata":"https://www.wikidata.org/wiki/Q428253","display_name":"Innate immune system","level":3,"score":0.24138566851615906}],"mesh":[],"locations_count":1,"locations":[{"id":"mag:2463913093","doi":null,"is_oa":false,"landing_page_url":"http://www.wseas.us/e-library/conferences/2010/Malta/MEDICAL/MEDICAL-19.pdf","pdf_url":null,"source":null,"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":32,"referenced_works":["https://openalex.org/W1921818371","https://openalex.org/W1967351091","https://openalex.org/W1984382389","https://openalex.org/W1988779510","https://openalex.org/W1991765113","https://openalex.org/W1995951039","https://openalex.org/W1999975217","https://openalex.org/W2026216011","https://openalex.org/W2034667224","https://openalex.org/W2044213834","https://openalex.org/W2045510035","https://openalex.org/W2047580124","https://openalex.org/W2064132909","https://openalex.org/W2067756762","https://openalex.org/W2076748580","https://openalex.org/W2085456770","https://openalex.org/W2100090035","https://openalex.org/W2102464054","https://openalex.org/W2109253148","https://openalex.org/W2112649783","https://openalex.org/W2120335459","https://openalex.org/W2121280124","https://openalex.org/W2130038503","https://openalex.org/W2132290252","https://openalex.org/W2137119310","https://openalex.org/W2140313585","https://openalex.org/W2142411891","https://openalex.org/W2144594946","https://openalex.org/W2147360611","https://openalex.org/W2154698511","https://openalex.org/W2164128280","https://openalex.org/W2166935931"],"related_works":["https://openalex.org/W2149490022","https://openalex.org/W2181140475","https://openalex.org/W2340639570","https://openalex.org/W1987623390","https://openalex.org/W2063065228","https://openalex.org/W2312793609","https://openalex.org/W987151669","https://openalex.org/W2188634889","https://openalex.org/W2047375049","https://openalex.org/W1593233137"],"abstract_inverted_index":{"\ufffb":[0],"Abstract\u2014":[1],"The":[2,40,84,111,138,154],"role":[3],"undertaken":[4],"by":[5,26,97],"antimicrobial":[6,23],"peptides":[7],"in":[8,12,35,57,81,92,117,134,144,163,167],"neutralizing":[9],"immune":[10,165],"inflammation":[11,166],"patients":[13,36,62,93,118,147,168],"with":[14,37,94,99,107,119,170],"infection":[15,96],"remains":[16],"unclear.":[17],"Human":[18],"cathelicidin":[19],"LL37":[20,52,88,113,162],"is":[21],"an":[22,54],"peptide":[24],"upregulated":[25],"1,25#hydroxyvitamin":[27],"D,":[28],"which":[29],"has":[30],"not":[31],"been":[32],"previously":[33],"studied":[34],"HCV":[38,61,95,145],"infection.":[39],"aim":[41],"of":[42,51,87,161],"our":[43],"study":[44],"was":[45,150],"to":[46,68,131],"evaluate":[47],"the":[48,70,74,141],"serum":[49,85],"levels":[50,114],"as":[53],"anti#inflammatory":[55],"factor":[56],"46":[58],"subjects":[59],"(25":[60],"and":[63,67,79,125,148],"21":[64],"healthy":[65],"controls)":[66],"investigate":[69],"potential":[71],"relationships":[72],"between":[73,140],"LL37,":[75],"25#":[76],"hydroxyvitamina":[77],"D":[78],"necroinflamation":[80],"these":[82],"patients.":[83],"concentrations":[86],"were":[89,115],"significantly":[90],"greater":[91],"comparison":[98],"values":[100,142],"obtained":[101,155],"from":[102],"controls":[103,135,149],"(12.2405":[104],"ng/ml":[105],"compared":[106,130],"9.9930":[108],"ng/ml,":[109],"p=0023).":[110],"highest":[112],"found":[116,143],"low":[120],"necroinflammatory":[121],"activity":[122],"(18.1426":[123],"ng/ml)":[124],"medium":[126],"fibrosis":[127],"(18.5578":[128],"ng/ml),":[129],"those":[132],"recorded":[133],"(9.9930":[136],"ng/ml).":[137],"difference":[139],"infected":[146,169],"statistically":[151],"significant":[152],"(p=0.023).":[153],"data":[156],"suggests":[157],"a":[158],"possible":[159],"involvement":[160],"chronic":[164],"HCV.":[171]},"counts_by_year":[{"year":2022,"cited_by_count":1}],"updated_date":"2026-10-01T08:54:57.152042","created_date":"2016-07-22T00:00:00"}